FIRST-IN-PEDIATRICS PHASE I STUDY OF GDC-0084 (PAXALISIB), A CNS-PENETRANT PI3K/MTOR INHIBITOR, IN NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR OTHER DIFFUSE MIDLINE GLIOMA (DMG)-MedSci.cn

FIRST-IN-PEDIATRICS PHASE I STUDY OF GDC-0084 (PAXALISIB), A CNS-PENETRANT PI3K/MTOR INHIBITOR, IN NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) OR OTHER DIFFUSE MIDLINE GLIOMA (DMG)

Tinkle, C; Huang, J; Campagne, O; Pan, HT; Onar-Thomas, A; Chiang, J; Klimo, P; Boop, R; Patay, Z; Shulkin, B; Lucas, J; Merchant, T; Upadhyaya, S; Robinson, G; Vinitsky, A; Stewart, C; Gajjar, A

NEURO-ONCOLOGY, 2020; 22 (): 48

科室
- - 订阅+
  - 更多科室
工具
服务